A self-amplifying nanodrug to manipulate the Janus-faced nature of ferroptosis for tumor therapy

A self-amplifying nanodrug was precisely designed to reprogram the Janus-faced nature of ferroptosis via harnessing the positive role of ferroptosis along with reversing its inherent negative role to achieve optimal ferroptotic tumor therapy.